Hospital Assisted Surgical Robot Procedures Market
Description
Size, Share & Trends Analysis Report By Application (Urology, General Surgery, Gynecology, Orthopedics, Cardiothoracic), By Procedure Type, By Procedure Complexity, By Region, And Segment Forecasts, 2026 - 2033
Hospital Assisted Surgical Robot Procedures Market Summary
The global hospital assisted surgical robot procedures market size was estimated at USD 11.07 billion in 2025 and is projected to reach USD 39.42 billion by 2033, growing at a CAGR of 17.3% from 2026 to 2033. The market is driven by the demand for minimally invasive surgeries, which reduce recovery time and complications while improving precision.
Adoption of advanced robotic technologies, rising investments in healthcare infrastructure, and the prevalence of complex surgical conditions are expanding the use of surgical robots. In January 2025, Warren Memorial Hospital in the U.S. began performing robotic-assisted general surgery using the da Vinci Xi system, enabling minimally invasive abdominal procedures with improved precision, reduced tissue damage, and faster patient recovery.
The market is driven by the rising demand for minimally invasive surgeries, which offer enhanced precision, reduced post-operative complications, and shorter patient recovery times. Robotic systems enable surgeons to perform complex procedures with greater accuracy and consistency, improving clinical outcomes and operational efficiency, thereby encouraging hospitals to integrate these technologies.In November 2025, Olean General Hospital in the U.S. announced plans to launch a robotic surgery program with the da Vinci Xi system in early 2026. The technology enables surgeons to perform procedures with precision, offering patients quicker recovery, less pain, and improved outcomes.
Integration of artificial intelligence, high-definition imaging, and multi-armed robotic systems allows healthcare providers to expand procedural capabilities, optimize workflow, and deliver higher-quality surgical care, particularly in tertiary and specialty hospitals. In February 2026, Nova Scotia Health’s QEII Health Sciences Centre introduced the da Vinci Xi robot with a USD 2.78 million donor contribution, enabling the province’s first robot-assisted colorectal, thoracic, and hepatobiliary surgeries. The system has already supported 56 procedures and expanded access to advanced care across multiple specialties.
Market growth is also propelled by the increasing availability of a skilled surgical workforce trained in robotic-assisted procedures, alongside favorable reimbursement frameworks and growing patient awareness of the benefits of robotic surgery. In February 2026, NHS East of England unveiled its National Cancer Plan, aiming to expand robot-assisted surgeries from 70,000 to 500,000 procedures by 2035 and to improve cancer care through faster diagnostics, specialist-centered treatment, and genomic testing. The plan includes same-day robotic prostatectomies and over 250 minimally invasive thoracic procedures, reducing hospital stays and enhancing recovery for patients across the region.
Global Hospital Assisted Surgical Robot Procedures Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global hospital assisted surgical robot procedures market report based on application, procedure type, procedure complexity, and region:
Hospital Assisted Surgical Robot Procedures Market Summary
The global hospital assisted surgical robot procedures market size was estimated at USD 11.07 billion in 2025 and is projected to reach USD 39.42 billion by 2033, growing at a CAGR of 17.3% from 2026 to 2033. The market is driven by the demand for minimally invasive surgeries, which reduce recovery time and complications while improving precision.
Adoption of advanced robotic technologies, rising investments in healthcare infrastructure, and the prevalence of complex surgical conditions are expanding the use of surgical robots. In January 2025, Warren Memorial Hospital in the U.S. began performing robotic-assisted general surgery using the da Vinci Xi system, enabling minimally invasive abdominal procedures with improved precision, reduced tissue damage, and faster patient recovery.
The market is driven by the rising demand for minimally invasive surgeries, which offer enhanced precision, reduced post-operative complications, and shorter patient recovery times. Robotic systems enable surgeons to perform complex procedures with greater accuracy and consistency, improving clinical outcomes and operational efficiency, thereby encouraging hospitals to integrate these technologies.In November 2025, Olean General Hospital in the U.S. announced plans to launch a robotic surgery program with the da Vinci Xi system in early 2026. The technology enables surgeons to perform procedures with precision, offering patients quicker recovery, less pain, and improved outcomes.
Integration of artificial intelligence, high-definition imaging, and multi-armed robotic systems allows healthcare providers to expand procedural capabilities, optimize workflow, and deliver higher-quality surgical care, particularly in tertiary and specialty hospitals. In February 2026, Nova Scotia Health’s QEII Health Sciences Centre introduced the da Vinci Xi robot with a USD 2.78 million donor contribution, enabling the province’s first robot-assisted colorectal, thoracic, and hepatobiliary surgeries. The system has already supported 56 procedures and expanded access to advanced care across multiple specialties.
Market growth is also propelled by the increasing availability of a skilled surgical workforce trained in robotic-assisted procedures, alongside favorable reimbursement frameworks and growing patient awareness of the benefits of robotic surgery. In February 2026, NHS East of England unveiled its National Cancer Plan, aiming to expand robot-assisted surgeries from 70,000 to 500,000 procedures by 2035 and to improve cancer care through faster diagnostics, specialist-centered treatment, and genomic testing. The plan includes same-day robotic prostatectomies and over 250 minimally invasive thoracic procedures, reducing hospital stays and enhancing recovery for patients across the region.
Global Hospital Assisted Surgical Robot Procedures Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global hospital assisted surgical robot procedures market report based on application, procedure type, procedure complexity, and region:
- Application Outlook (Revenue USD Million, 2021 - 2033)
- Urology
- General Surgery
- Gynecology
- Orthopedics
- Cardiothoracic
- Neurosurgery
- ENT (Otolaryngology)
- Bariatric / Metabolic
- Other specialties
- Procedure Type Outlook (Revenue USD Million, 2021 - 2033)
- Minimally-invasive laparoscopic robotic-assisted
- Endoscopic robotic procedures
- Open-assisted (hybrid open procedures)
- Others (Percutaneous / catheter-based robotic, novel)
- Procedure Complexity Outlook (Revenue USD Million, 2021 - 2033)
- High complexity (oncologic, cardiac, neuro)
- Medium complexity (advanced laparoscopy, joint replacements)
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Procedure type outlook
- 2.2.3. Procedure complexity outlook
- 2.3. Competitive Insights
- Chapter 3. Global Hospital Assisted Surgical Robot Procedures Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Global Hospital Assisted Surgical Robot Procedures: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s Five Forces Analysis
- 3.3.2. PESTLE Analysis
- 3.4. Technology Landscape
- 3.5. Case Study Analysis
- Chapter 4. Global Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Application, 2021 - 2033 (USD Million)
- 4.1. Definition and Scope
- 4.2. Application Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Hospital Assisted Surgical Robot Procedures Market, by Application, 2021 to 2033
- 4.5. Urology
- 4.5.1. Urology market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6. General Surgery
- 4.6.1. General surgery market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.7. Gynecology
- 4.7.1. Gynecology market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.8. Orthopedics
- 4.8.1. Orthopedics market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.9. Cardiothoracic
- 4.9.1. Cardiothoracic market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.10. Neurosurgery
- 4.10.1. Neurosurgery market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.11. ENT (Otolaryngology)
- 4.11.1. ENT (Otolaryngology) market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.12. Bariatric / Metabolic
- 4.12.1. Bariatric / metabolic market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.13. Others
- 4.13.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 5. Global Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Procedure Type, 2021 - 2033 (USD Million)
- 5.1. Definition and Scope
- 5.2. Procedure Type Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Hospital Assisted Surgical Robot Procedures Market, by Procedure Type, 2021 to 2033
- 5.5. Minimally-invasive laparoscopic robotic-assisted
- 5.5.1. Minimally-invasive laparoscopic robotic-assisted market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.6. Endoscopic robotic procedures
- 5.6.1. Endoscopic robotic procedures market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.7. Open-assisted (hybrid open procedures)
- 5.7.1. Open-assisted (hybrid open procedures) market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.8. Others (Percutaneous / catheter-based robotic, novel)
- 5.8.1. Others (Percutaneous / catheter-based robotic, novel) market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 6. Global Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Procedure Complexity, 2021 - 2033 (USD Million)
- 6.1. Definition and Scope
- 6.2. Procedure Complexity Market Share Analysis, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global Hospital Assisted Surgical Robot Procedures Market, by Procedure Complexity, 2021 to 2033
- 6.5. High Complexity
- 6.5.1. High complexity market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.6. Medium Complexity
- 6.6.1. Medium complexity market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 7. Hospital Assisted Surgical Robot Procedures Market Segment Analysis, By Region, 2021 - 2033 (USD Million)
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Hospital Assisted Surgical Robot Procedures Market Share by Region, 2025 & 2033:
- 7.5. North America
- 7.5.1. North America hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Scenario
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. U.S. hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Scenario
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Canada hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Regulatory Scenario
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Mexico hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6. Europe
- 7.6.1. Europe hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.2. UK
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Scenario
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. UK hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Scenario
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Germany hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Scenario
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. France hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Regulatory Scenario
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Italy hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Regulatory Scenario
- 7.6.6.3. Competitive Scenario
- 7.6.6.4. Spain hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.7. Norway
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Regulatory Scenario
- 7.6.7.3. Competitive Scenario
- 7.6.7.4. Norway hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Regulatory Scenario
- 7.6.8.3. Competitive Scenario
- 7.6.8.4. Sweden hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.6.9. Denmark
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Regulatory Scenario
- 7.6.9.3. Competitive Scenario
- 7.6.9.4. Denmark hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.7.2. Japan
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Regulatory Scenario
- 7.7.2.3. Competitive Scenario
- 7.7.2.4. Japan hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Regulatory Scenario
- 7.7.3.3. Competitive Scenario
- 7.7.3.4. China hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Regulatory Scenario
- 7.7.4.3. Competitive Scenario
- 7.7.4.4. India hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.7.5. Australia
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Regulatory Scenario
- 7.7.5.3. Competitive Scenario
- 7.7.5.4. Australia hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.7.6. South Korea
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Regulatory Scenario
- 7.7.6.3. Competitive Scenario
- 7.7.6.4. South Korea hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key Country Dynamics
- 7.7.7.2. Regulatory Scenario
- 7.7.7.3. Competitive Scenario
- 7.7.7.4. Thailand hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.8.2. Brazil
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Regulatory Scenario
- 7.8.2.3. Competitive Scenario
- 7.8.2.4. Brazil hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Regulatory Scenario
- 7.8.3.3. Competitive Scenario
- 7.8.3.4. Argentina hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.9. MEA
- 7.9.1. MEA hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Regulatory Scenario
- 7.9.2.3. Competitive Scenario
- 7.9.2.4. South Africa hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Regulatory Scenario
- 7.9.3.3. Competitive Scenario
- 7.9.3.4. Saudi Arabia hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Regulatory Scenario
- 7.9.4.3. Competitive Scenario
- 7.9.4.4. UAE hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Regulatory Scenario
- 7.9.5.3. Competitive Scenario
- 7.9.5.4. Kuwait hospital assisted surgical robot procedures market, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Intuitive Surgical
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. THINK Surgical, Inc.
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Smith+Nephew
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Medtronic
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Stryker
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Zimmer Biomet
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. CMR Surgical
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Asensus Surgical US, Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Renishaw PLC.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. MOON Surgical
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
